Cell
Volume 184, Issue 12, 10 June 2021, Pages 3143-3162.e32
ArticleThe PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
Under an Elsevier user license
open archive
Graphical abstract
Keywords
transcriptional elongation
CDK9
Integrator
phosphatase
PP2A
cancer
RNA polymerase II
CRISPR-Cas9 screen
pause-release
PP2A activation
CTD
Cited by (0)
© 2021 Elsevier Inc.